Every SEC Form 3/4/5 on record for this filer (CIK 1436861) — 6 issuers, 38 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| WST | WEST PHARMACEUTICAL SERVICES INC | Director | 2016-09-13 → 2026-05-06 | 13 | — |
| REPL | Replimune Group, Inc. | Director | 2020-04-02 → 2026-04-07 | 8 | — |
| MRUS | Merus N.V. | Director | 2020-07-02 → 2025-12-12 | 8 | — |
| TRIL | Trillium Therapeutics Inc. | Director · lapsed | 2021-01-04 → 2021-11-19 | 2 | — |
| ARQL | ARQULE INC | Chief Executive Officer · Director · lapsed | 2015-12-11 → 2020-01-16 | 24 | $130,720 |
| DYAX | DYAX CORP | Filer · lapsed | 2016-01-15 → 2016-01-22 | 2 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
2 of 6 issuers are covered and open a security page; the rest are on file here only.